myNEO Therapeutics: a little history
myNEO was founded in 2018 by leading biotech entrepreneurs combining expertise from different academic institutions. Cedric Bogaert, Jan Van Den Berghe, and Wim van Criekinge have since then expanded the team with established domain in antigen discovery experts as well as ambitious talent to further grow the company's innovation and developments.
To date, myNEO has achieved several pivotal milestones in realizing its vision. These include:
- Development of state-of-the-art neoMS and neoIM antigen prediction algorithms
- Discovery of novel, dark antigen targets called camyotopes
- (Co-)development of novel immunotherapeutics products via strategic collaborations or in-house, leading to 3 separate programs executing successful IND/CTA filings in 2025
- The publication of high-impact scientific papers
- ISO and regulatory approval for clinical use of technology
- Securing valuable intellectual property with multiple patents
- Receiving several prestigious awards (Most Disruptive Innovator, Forbes 30under30, Rising Star Fast50)
The people behind myNEO
Team
Board
Advisors
Where is myNEO Therapeutics located?
myNEO Therapeutics is headquartered at Ottergemsesteenweg 439, 9000 Ghent, Belgium.
When was myNEO Therapeutics founded?
myNEO was founded in Ghent, Belgium, in December 2018 by Cedric Bogaert, Jan Van Den Berghe, and Wim van Criekinge as the third company incorporated by Novalis Biotech Incubation. It was established to identify, explore, and validate targets for personalized cancer immunotherapy, forming the technological basis for the ImmunoEngine platform.
Is myNEO's technology supported by peer-reviewed publications?
Yes. The neoMS and neoIM algorithms are described in Mill et al., bioRxiv 2022, and Pfitzer et al., Vaccines 2025;13(8):865, respectively. Two peer-reviewed articles provide broader context: Lybaert et al., Trends Cancer 2023;9(6):503-519, and Lybaert et al., Cancer Cell 2023;41(1):15-40. Additional technology papers and whitepapers cover myNEO solutions and research.
Talk to our team
Discuss a partnership, a scientific collaboration, or how to work with the myNEO team.